Kwan Hou Tang
Research Subjects
Kwan Hou Tang has a total of 18 co-authors. Here are the top co-authors by number of shared publications:
- Gielenny M. Salem
Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung Hsing University, Taichung City, Taiwan
2 shared publications - Suan-Sin Foo
Department of Microbial Sciences in Health, Cleveland Clinic, Cleveland, USA
2 shared publications - Anne W. Rimoin
Department of Epidemiology, Jonathan and Karin Fielding School of Public Health, University of California, Los Angeles, CA, USA
1 shared publication Dallas Swendeman
Department of Psychiatry & Biobehavioral Sciences, David Geffen School of Medicine, University of California, Los Angeles, USA
1 shared publicationDébora Familiar-Macedo
Laboratory of Virus-Host Interactions (LIVH), Oswaldo Cruz Institute (IOC), Oswaldo Cruz Foundation (Fiocruz)
1 shared publicationElizabeth Mayfield Arnold
Department of Psychiatry, University of Kentucky College of Medicine, Lexington, USA
1 shared publication
Latest Publications
- 12 November 2026
- Published by American Society for Microbiology in Clinical Microbiology Reviews
Maternal-fetal health in arboviral diseases: clinical outcomes following prenatal dengue and chikungunya virus infections
SUMMARY: Arthropod-borne viruses (arboviruses) are an increasingly important cause of global infectious disease, yet their effects during pregnancy and early life remain incompletely understood. In the context of declining fertility and birth rates globally, infectious threats to successful pregnancy and neonatal health warrant greater attention. Dengue virus (DENV) and chikungunya virus (CHIKV), two of the most prevalent mosquito-borne viruses, are underrecognized contributors to maternal-fetal health. Although these infections rarely result in classical congenital syndromes, accumulating clinical, epidemiological, and experimental evidence indicates that prenatal exposure can impair placental function, drive maternal immune dysregulation, and influence fetal and neonatal immune development. This review summarizes current knowledge on the maternal, placental, and pediatric consequences of DENV and CHIKV infection during pregnancy. We outline the immunological features of the maternal-fetal interface and discuss how pregnancy-associated immune modulation shapes antiviral responses and placental homeostasis. We then review epidemiological and clinical evidence linking prenatal arboviral infection with adverse pregnancy outcomes, neonatal disease, and potential long-term neurodevelopmental effects. Mechanistic insights, including viral immune evasion, placental inflammation, and antibody-mediated immunopathology, are examined. Finally, we discuss clinical considerations for monitoring arboviral-exposed pregnancies and progenies, alongside emerging strategies to reduce maternal infection and improve neonatal outcomes.
- 12 November 2026
- Published by American Society for Microbiology in Clinical Microbiology Reviews
Maternal-fetal health in arboviral diseases: clinical outcomes following prenatal dengue and chikungunya virus infections
SUMMARY: Arthropod-borne viruses (arboviruses) are an increasingly important cause of global infectious disease, yet their effects during pregnancy and early life remain incompletely understood. In the context of declining fertility and birth rates globally, infectious threats to successful pregnancy and neonatal health warrant greater attention. Dengue virus (DENV) and chikungunya virus (CHIKV), two of the most prevalent mosquito-borne viruses, are underrecognized contributors to maternal-fetal health. Although these infections rarely result in classical congenital syndromes, accumulating clinical, epidemiological, and experimental evidence indicates that prenatal exposure can impair placental function, drive maternal immune dysregulation, and influence fetal and neonatal immune development. This review summarizes current knowledge on the maternal, placental, and pediatric consequences of DENV and CHIKV infection during pregnancy. We outline the immunological features of the maternal-fetal interface and discuss how pregnancy-associated immune modulation shapes antiviral responses and placental homeostasis. We then review epidemiological and clinical evidence linking prenatal arboviral infection with adverse pregnancy outcomes, neonatal disease, and potential long-term neurodevelopmental effects. Mechanistic insights, including viral immune evasion, placental inflammation, and antibody-mediated immunopathology, are examined. Finally, we discuss clinical considerations for monitoring arboviral-exposed pregnancies and progenies, alongside emerging strategies to reduce maternal infection and improve neonatal outcomes.
- Open Access
- 25 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Distinct inflammatory marker profiles of adolescents and young adults among the HIV risk, infection, and treatment spectrum
Youth living with or at HIV-risk exhibit distinct immune perturbations during HIV exposure, infection, and antiretroviral therapy (ART). Understanding immune perturbations is critical for development of tailored prevention and enhanced therapeutic strategies. We performed plasma proteomic profiling of 49 biomarkers using Luminex multiplex assay in 262 participants (mean age of 21.9 years), including healthy controls, high-risk youth without HIV (HRY), newly diagnosed youth living with HIV (NY), and previously diagnosed youth on ART for over 24 months (PY), and report distinct immune landscapes. Among HRY, we observe dysregulation of circulating interferon-driven inflammation. NY display overt systemic inflammation at diagnosis, which partially resolves but does not fully normalize within 24 months of ART. PY display largely normalized immune profiles, though circulating signatures consistent with residual checkpoint activation persist. Our results identify conserved and stage-specific, circulating inflammatory modulators and key transcriptional regulators delineating HIV susceptibility, progression, and long-term treatment responses.
- 25 September 2026
- Published by Springer Nature in Nature Communications
- Vol. 17 (1)
Open AccessDistinct inflammatory marker profiles of adolescents and young adults among the HIV risk, infection, and treatment spectrum
Youth living with or at HIV-risk exhibit distinct immune perturbations during HIV exposure, infection, and antiretroviral therapy (ART). Understanding immune perturbations is critical for development of tailored prevention and enhanced therapeutic strategies. We performed plasma proteomic profiling of 49 biomarkers using Luminex multiplex assay in 262 participants (mean age of 21.9 years), including healthy controls, high-risk youth without HIV (HRY), newly diagnosed youth living with HIV (NY), and previously diagnosed youth on ART for over 24 months (PY), and report distinct immune landscapes. Among HRY, we observe dysregulation of circulating interferon-driven inflammation. NY display overt systemic inflammation at diagnosis, which partially resolves but does not fully normalize within 24 months of ART. PY display largely normalized immune profiles, though circulating signatures consistent with residual checkpoint activation persist. Our results identify conserved and stage-specific, circulating inflammatory modulators and key transcriptional regulators delineating HIV susceptibility, progression, and long-term treatment responses.